EGFR testing in lung cancer is ready for prime time

Lancet Oncol. 2009 May;10(5):432-3. doi: 10.1016/S1470-2045(09)70110-X.
No abstract available

Publication types

  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung / chemistry
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / genetics
  • ErbB Receptors / analysis*
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / genetics
  • Gene Amplification
  • Humans
  • Lung Neoplasms / chemistry
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics
  • Mutation
  • Protein Kinase Inhibitors / therapeutic use*

Substances

  • Protein Kinase Inhibitors
  • ErbB Receptors